| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |